Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
NeuroVive presents positive preclinical data in hepatocellular cancer at HCC Summit
January 19, 2017 Off

NeuroVive presents positive preclinical data in hepatocellular cancer at HCC Summit

By Dino Mustafić

NeuroVive Pharmaceutical’s abstract with novel preclinical cancer data related to the company’s sanglifehrin-based compounds has been accepted for presentation at…

Summit Therapeutics’s R&D adviser becomes COO, President of Research Development
January 19, 2017 Off

Summit Therapeutics’s R&D adviser becomes COO, President of Research Development

By Dino Mustafić

Summit Therapeutics has named its research and development adviser Dr David Roblin as new Chief Operating Officer (COO) and President of Research Development.

PledPharma’s Nomination Committee wants board changes
January 19, 2017 Off

PledPharma’s Nomination Committee wants board changes

By Dino Mustafić

PledPharma’s Nomination Committee has submitted a proposal for a new composition of the Board of Directors for consideration at an…

GSK takes AstraZeneca’s European Executive Vice President to its team
January 19, 2017 Off

GSK takes AstraZeneca’s European Executive Vice President to its team

By Dino Mustafić

GlaxoSmithKline has appointed Luke Miels President, Global Pharmaceuticals, GSK. He will be responsible for a portfolio of medicines and vaccines with annual sales of more than £15 billion and operations in over 100 markets.

Adocia plans private placement, wants to partner up on “more mature projects”
January 19, 2017 Off

Adocia plans private placement, wants to partner up on “more mature projects”

By Dino Mustafić

French drugmaker Adocia, encouraged by the outcome of its project BC Lispro, has set its goal on partnering up with companies that have “more mature projects”, such is Eli Lilly with whom Adocia worked on BC Lispro.

January 18, 2017 Off

FDA warns Horizon Pharmaceuticals about drug products contamination

By Dino Mustafić

Horizon Pharmaceuticals has warned by the Food and Drug Administration (FDA) to better respond on resolving certain issues it had in its drug manufacturing facilities, that the FDA pointed out after an inspection in 2015.

Lilly buys a near-billion dollars worth company and gets its prospective migraine drug back
January 18, 2017 Off

Lilly buys a near-billion dollars worth company and gets its prospective migraine drug back

By Dino Mustafić

Eli Lilly has bought a biotech company focusing on pain management, CoLucid Pharmaceuticals for approximately $960 million, ($46.50 per share)…

Moberg Pharma expands New Skin retail presence
January 18, 2017 Off

Moberg Pharma expands New Skin retail presence

By Dino Mustafić

Moberg Pharma’s New Skin Spray SKU will be sold in 3,900 Walmart stores and in over 1,500 Walgreens stores.

FDA OK’s Hikma’s US subsidiary’s narcolepsy drug
January 18, 2017 Off

FDA OK’s Hikma’s US subsidiary’s narcolepsy drug

By Dino Mustafić

Hikma Pharmaceuticals’s US subsidiary Roxane Laboratories has received an approval from the US Food and Drug Administration for its Sodium…

MDxHealth’s prostate cancer drug gets positive medical policy from Horizon BCBS
January 18, 2017 Off

MDxHealth’s prostate cancer drug gets positive medical policy from Horizon BCBS

By Dino Mustafić

Horizon Blue Cross Blue Shield (Horizon BCBS) of New Jersey has issued a positive medical policy for the MDxHealth’s ConfirmMDx for Prostate Cancer test.

Posts pagination

Previous 1 … 3,523 3,524 3,525 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine